CORINNE REILLY: Open Payments
NPI 1043647415 · MOUNT KISCO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,584 in 132 payments from 17 companies in 2025. Trend: 2023 $2,543 · 2024 $2,864 · 2025 $2,584
Food & beverage: $2,512Education: $72
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $463 |
| Incyte Corporation | 19 | $371 |
| Janssen Biotech, Inc. | 12 | $316 |
| GENZYME CORPORATION | 8 | $288 |
| Galderma Laboratories, L.P. | 25 | $273 |
| LEO Pharma Inc. | 7 | $172 |
| Novartis Pharmaceuticals Corporation | 6 | $117 |
| Amgen Inc. | 4 | $116 |
| Regeneron Healthcare Solutions, Inc. | 4 | $111 |
| UCB, Inc. | 3 | $111 |
Products named: DUPIXENT, Opzelura, SKYRIZI, TREMFYA, NEMLUVIO, ADBRY, Otezla, RINVOQ.
Industry payments across NY — which companies pay providers there.
